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In this issueof Immunity, Hall et al. (2011) showthat vitaminAand itsmetabolitesplayacentral role in regulating
adaptive immunity by promoting the development of both inflammatory and regulatory T cell responses.VitaminA isanessential fat-solublenutrient
that is required for the development of
many organs and tissues. It is converted
into several metabolically active deriva-
tives, including retinoic acid (RA). RA is
a potent regulatory molecule that controls
gene expression through RA receptors
(RARs), members of the nuclear hormone
receptor family that activate the transcrip-
tion of specific target genes. The RA-RAR
signaling machinery represents an evolu-
tionarily ancient gene regulatory pathway,
which is conserved in all vertebrates and
invertebrate chordates. It appears to have
evolved as a core regulatory network that
governs cell fate specification during
developmental patterning. In vertebrates,
RA also plays important roles in the devel-
opment of specific immunity, directing
immunoglobulin class switching in B cells
and inducing gut homing receptors on B
and T lymphocytes. However, until rela-
tively recently there was little known about
how RA impacts T cell development.
In 2007, a raft of landmark papers from
several laboratories revealed a critical rolefor RA in directing intestinal CD4+ T cell
development (Benson et al., 2007;
Coombes et al., 2007; Denning et al.,
2007; Mucida et al., 2007; Sun et al.,
2007). According to these initial studies,
this effect was restricted to a particular
subset of CD4+ T cells. CD4+ T cells can
develop along one of several distinct path-
ways that dictate the type of immune
response that ensues. T helper type 1
(Th1) and Th17 cell developmental subsets
are associated with aggressive proinflam-
matory responses to infection, whereas T
regulatory (Treg) cells constitute a distinct
developmental subset that is associated
with immune responses that prevent or
dampen inflammation. Each of the studies
from 2007 showed that RA signaling trig-
gered intestinal Treg cell development.
A specific subset of intestinal dendritic cells
(DCs) produced RA, which synergized with
thecytokineTGF-b to induceFoxp3 innaive
CD4+ T cells, promoting differentiation
along the Treg cell pathway (Coombes
et al., 2007; Sun et al., 2007). At the same
time, other studies revealed that RA in-hibited Th17 cell development, leading to
the idea of RA as an anti-inflammatory
factor that promotes intestinal Treg cell
differentiation at the expense of Th17 cell
development (Elias et al., 2008; Mucida
et al., 2007).
In this issue of Immunity, Hall et al. (2011)
challenge the idea thatRA is ananti-inflam-
matory factor that restricts T cell differenti-
ation to the Treg cell pathway. Instead, the
authors show that RA plays a much
broader role in controlling CD4+ T cell fate
(Figure 1). To investigate the role of vitamin
A and its metabolites in CD4+ T cell
responses during infection, Hall et al. put
mice on a diet lacking vitamin A. They
then provoked inflammation by using
Toxoplasma gondii, an intracellular proto-
zoan parasite that normally enters the
body through the gastrointestinal tract,
eliciting robust mucosal inflammation and
a strong systemic Th1 cell response.
When Hall et al. examined CD4+ T cells
after oral infection with T. gondii, they
observed thatmiceonavitaminA-deficient
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Figure 1. RA Promotes Multiple CD4+ T Cell Effector Responses through RARa Activation
RA was previously thought to be a critical switch factor that promotes Treg cell differentiation but inhibits
Th1 and Th17 cell differentiation. However, Hall et al. (2011) demonstrate that RA is also required for Th1
and Th17 cell responses to infection and vaccination and is therefore a broad regulator of CD4+ T cell
responses. RA is delivered to T cells, where it activates RA receptor alpha (RARa), a member of the nuclear
hormone receptor family. RARa partners with members of the retinoid X receptor (RXR) family to activate
transcription of genes that have RA response elements (RAREs) in their promoters. This promotes differ-
entiation of naive T cells to fully functional effector cells that can drive proinflammatory responses to infec-
tion. The likely source of RA is antigen-presenting cells, such as dendritic cells or macrophages. These
cells express enzymes, including alcohol dehydrogenases (ADHs) and retinaldehyde dehydrogenases
(RALDHs), that convert vitamin A (retinol) to RA. The mechanism of RA transfer between dendritic cells
and T cells remains unknown.
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Moreover, the vitamin A-deficient mice
were infectedwithmoreT. gondiiparasites
at both mucosal and systemic sites, and
this difference was observed regardless
of whether the pathogen was inoculated
via the natural oral route or injected
systemically. Importantly, robust CD4+
T cell immunity to T. gondii was restored
by simply feeding RA to the vitamin A-defi-
cientmice. These results indicate thatRA is
critically important for theTcell response to
T. gondii and strongly challenge the model
ofRAasananti-inflammatory factorwhose
effects are restricted to mucosal tissues.
Instead, the findings show that RA
signaling is sustained during infection and
promotes the development of an inflam-
matory Th1 cell response at both mucosal
and systemic sites.
Hall et al. also probedRA involvement in
T cell responses to vaccination. Employ-
ing ovalbumin as a model antigen, they
found that oral inoculation of vitamin A-
deficient mice fails to elicit Th1 and Th17
cell responses that occur in mice on
a normal diet. Thus, vitamin A is essential
for both Th1 and Th17 cell responses to
oral vaccination. As with T. gondii
challenge, simply feeding RA to vitamin
A-deficient mice restored their ability torespond to mucosal vaccination. As
discussed below, this finding has tremen-
dous implications for designing vaccina-
tion strategies in human populations,
particularly in the face of malnutrition.
The profound impact of RA on CD4+
T cell immunity raises the question of
how RA imparts its effects to T cells. In
other physiological systems RA activates
specific gene expression programs
through RARs. Moreover, RA is known
to drive Treg cell differentiation by acti-
vating RARa, one of the three members
of the RAR family (Nolting et al., 2009).
Similarly, Hall et al. found that mice lack-
ing RARa showed severely impaired Th1
cell responses to oral vaccination with
ovalbumin, establishing that RARa also
activates pro-inflammatory CD4+ T re-
sponses. RARa triggered signal transduc-
tion events downstream of the T cell
receptor that direct T cell activation,
arguing that RA-RARa signaling occurs
within the T cells themselves rather than
through an indirect route. Thus, it seems
that T cells have co-opted the evolution-
arily ancient RA-RAR signaling machinery
to govern regulatory networks that are
fundamental for their development.
The finding that RA directs proinflamma-
tory T cell responses is in direct conflictImmunity 3with earlier reports, which showed that RA
strongly inhibited Th17 cell polarization
in vitro (Elias et al., 2008; Mucida et al.,
2007).Whataccounts for thisdiscrepancy?
Hall et al. suggest the importance of two
factors. First, RA concentration appears
to be critical in determining whether Th17
cell differentiation is activated, with lower
RA concentrations (1–10 nM) stimulating
and higher concentrations (>100 nM) sup-
pressing Th17 cell responses (Wang et al.,
2010). Second, the presence of microbial
antigens may be critical in determining the
outcome of RA stimulation of naive
T cells. For example, the Toll-like receptor
5 ligand flagellin stimulates intestinal DCs
to both produce RA and induce Th17 cell
differentiation (Uematsu et al., 2008).
However, it will be important to investigate
whether there are in vivo situations inwhich
RA represses Th17 cell development and
to determine under what conditions RA
activates proinflammatory versus anti-
inflammatory T cell responses.
A major remaining question concerns
thesourceof theRA that stimulates inflam-
matory T cell responses in vivo. T cell
development is typically triggered by inter-
actions with antigen-presenting cells
(APCs) that involve direct cell-cell contact
that is co-incident with T cell receptor
engagement. Two lines of evidence
suggest that APCs such as DCs might
supply the RA that promotes Th1 cell and
Th17 cell differentiation. First, intestinal
DCs express enzymes that convert retinol
to RA (Coombes et al., 2007). Second,
DCs supply the RA that induces intestinal
Treg cell development (Coombes et al.,
2007; Sun et al., 2007), suggesting that
they may perform a similar function in
proinflammatory T cell development. It is
not yet clear whether systemicDCsharbor
RA generating machinery or whether RA
production is restricted to mucosal DCs.
However, given that both mucosal and
systemic immune responses to T. gondii
require RA, it seems likely that RA produc-
tion may be a general feature of DCs.
Although it is currently not clear how RA
is transported between neighboring cells,
its lipid solubility suggests that it may be
able to permeate adjacent membranes.
We speculate that RAmay act as a general
signal that contact has been achieved
between an APC and a T cell. Passage of
RA from the APC to the T cell could act
as a ‘‘molecular handshake’’ to signal
stable cell-cell contact, setting the stage4, March 25, 2011 ª2011 Elsevier Inc. 291
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mental programs. In this regard, RA
signaling in T cell development may be
similar to the induction of devel-
opmental patterning, where RA signals
are frequently passed between adjacent
cells, triggeringgeneexpressionprograms
that convey positional information.
The findings of the Hall et al. study have
profound implications for public health.
First, they indicate that adequate vitamin
A intake is critical for productive T cell
responses to infection. This idea is sup-
ported by the markedly increased suscep-
tibility to infection that is a hallmark of
vitamin A deficiency in humans. Second,
they indicate that mucosal vaccination in
the face of poor nutrition is likely to yield
suboptimal results. The fact thatRA feeding292 Immunity 34, March 25, 2011 ª2011 Elserestored robust CD4+ T cell responses in
vitamin A-deficient mice suggests vitamin
A or RA supplementation as a strategy to
increase theefficacyofvaccination. Inother
words, you should eat your carrots.
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